Earli (Series A+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$120,000,000
Company Info
Founders
Cyriac Roeding
Market
Healthcare & Wellness
Coinvestors
AH Bio Fund,Khosla Ventures
Company Description

A biotech company developing a new approach to cancer detection. Earli is a developer of cancer treatment devices designed to search for natural biomarkers.